166 related articles for article (PubMed ID: 11037182)
1. Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals.
Tateishi J
Neuropathology; 2000 Sep; 20 Suppl():S20-4. PubMed ID: 11037182
[TBL] [Abstract][Full Text] [Related]
2. Cervical MRI of subacute myelo-optico-neuropathy.
Kimura E; Hirano T; Yamashita S; Hirai T; Uchida Y; Maeda Y; Uchino M
Spinal Cord; 2011 Feb; 49(2):182-5. PubMed ID: 20548321
[TBL] [Abstract][Full Text] [Related]
3. Subacute myelo-optic neuropathy (SMON). First neuro-pathological report outside Japan.
Ricoy JR; Ortega A; Cabello A
J Neurol Sci; 1982 Feb; 53(2):241-51. PubMed ID: 6460092
[TBL] [Abstract][Full Text] [Related]
4. [SMON: toxicity of clioquinol and the status quo].
Konagaya M
Brain Nerve; 2015 Jan; 67(1):49-62. PubMed ID: 25585435
[TBL] [Abstract][Full Text] [Related]
5. Depression in patients with subacute myelo-optico-neuropathy (SMON).
Konishi T; Hayashi K; Hayashi M; Ueno S; Yoshida S; Fujimura H; Funakawa I; Kaido M
Intern Med; 2008; 47(24):2127-31. PubMed ID: 19075537
[TBL] [Abstract][Full Text] [Related]
6. [Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON)].
Katsuyama M
Nihon Yakurigaku Zasshi; 2024; 159(2):78-82. PubMed ID: 38432923
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of longstanding subacute myelo-optico-neuropathy: sequelae of clioquinol at 32 years after its ban.
Konagaya M; Matsumoto A; Takase S; Mizutani T; Sobue G; Konishi T; Hayabara T; Iwashita H; Ujihira T; Miyata K; Matsuoka Y
J Neurol Sci; 2004 Mar; 218(1-2):85-90. PubMed ID: 14759638
[TBL] [Abstract][Full Text] [Related]
8. Tongue strength in patients with subacute myelo-optico-neuropathy.
Yamashita S; Nakama T; Ueda M; Honda S; Kimura E; Konagaya M; Ando Y
J Clin Neurosci; 2018 Jan; 47():84-88. PubMed ID: 29054330
[TBL] [Abstract][Full Text] [Related]
9. [Fifity years after the identification of the cause of SMON].
Kuru S
Rinsho Shinkeigaku; 2021 Feb; 61(2):109-114. PubMed ID: 33504748
[TBL] [Abstract][Full Text] [Related]
10. Physical Disabilities Related to the Depressive Mental States of Japanese Patients with Subacute Myelo-optico-neuropathy.
Konishi T
Intern Med; 2018 Sep; 57(18):2641-2645. PubMed ID: 29780125
[TBL] [Abstract][Full Text] [Related]
11. [SMON--a model of the iatrogenic disease].
Takasu T
Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
[TBL] [Abstract][Full Text] [Related]
12. Subacute myelo-optico-neuropathy (SMON) in Japan. With special reference to the autopsy cases.
Egashira Y; Matsuyama H
Acta Pathol Jpn; 1982; 32 Suppl 1():101-16. PubMed ID: 6316716
[TBL] [Abstract][Full Text] [Related]
13. Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?
Schaumburg H; Herskovitz S
Neurology; 2008 Aug; 71(9):622-3. PubMed ID: 18725588
[No Abstract] [Full Text] [Related]
14. SMON as seen from Bombay.
Wadia NH
Acta Neurol Scand Suppl; 1984; 100():159-64. PubMed ID: 6091394
[TBL] [Abstract][Full Text] [Related]
15. Diminished skin vasodilator response to local heating in patients with long-standingsubacute myelo-optico-neuropathy.
Yamanaka Y; Asahina M; Akaogi Y; Koyama Y; Hattori T
J Neurol Sci; 2007 Sep; 260(1-2):214-8. PubMed ID: 17572442
[TBL] [Abstract][Full Text] [Related]
16. The neuropathology of subacute myelo-optico-neuropathy, "SMON", in the humans: --with special reference to the quinoform intoxication.
Shiraki H
Jpn J Med Sci Biol; 1975; 28 Suppl():101-64. PubMed ID: 136535
[TBL] [Abstract][Full Text] [Related]
17. Founder genetic variants of ABCC4 and ABCC11 in the Japanese population are not associated with the development of subacute myelo-optico-neuropathy (SMON).
Matsumoto H; Sasai H; Kawamoto N; Katsuyama M; Minamiyama M; Kuru S; Fukao T; Ohnishi H;
Mol Genet Genomic Med; 2022 Jan; 10(1):e1845. PubMed ID: 34951141
[TBL] [Abstract][Full Text] [Related]
18. Superoxide dismutase as a target of clioquinol-induced neurotoxicity.
Kawamura K; Kuroda Y; Sogo M; Fujimoto M; Inui T; Mitsui T
Biochem Biophys Res Commun; 2014 Sep; 452(1):181-5. PubMed ID: 24755073
[TBL] [Abstract][Full Text] [Related]
19. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
Shigematsu I
Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
[No Abstract] [Full Text] [Related]
20. Loss-of-function polymorphisms in NQO1 are not associated with the development of subacute myelo-optico-neuropathy.
Matsumoto H; Sasai H; Kawamoto N; Katsuyama M; Minamiyama M; Kuru S; Fukao T; Ohnishi H;
Mol Genet Genomic Med; 2024 Jun; 12(6):e2470. PubMed ID: 38860482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
